Trade names from 'co-exforg®' to 'cocarboxylase' - Electronic medicinal guide TALKDRUGS

Tablets, film-coated, 5 mg + 160 mg + 12.5 mg, 10 mg + 160 mg + 12.5 mg.

Novartis Pharma AG Switzerland
Lyophilizate for the preparation of a solution for intravenous injection of 1.2 mg, 2.4 mg or 4.8 mg.
T wrapped film coated abomasum, 12.5 mg each. Packing for hospitals: 30 tablets in PVC / Al blister. 1 blister with instruction on

Lyophilizate for the preparation of a solution for intravenous administration, 250 ME and 500 ME.

Film-coated tablets, 300 mg / 25 mg.
Tablets 150 mg / 12.5 mg and 300 mg / 12.5 mg.
Tablets, film-coated, 12.5 mg + 150 mg and 12.5 mg + 300 mg.

Lyophilizate for solution for intravenous administration, 250 ME, 500 ME, 1000 ME or 2000 ME.

Solution for oral administration 25 mg / ml.
Syrup 1.5 mg / ml.
Drops for ingestion 5 mg / ml.
Tablets with modified release, film-coated, 50 mg.
Film-coated tablets 50 mg.
Film coated tablets 100 mg.
Lyophilizate for the preparation of a solution for subcutaneous administration, 150 mg.
Novartis Pharma AG Switzerland
A solution for subcutaneous administration, 150 mg / ml.
Novartis Pharma AG Switzerland
Lyophilizate for the preparation of solution for intramuscular injection.

Lyophilizate for the preparation of solution for intramuscular injection 50 mg.

Lyophilizate for the preparation of a solution for intravenous and intramuscular injection of 50 mg in ampoules.

Lyophilizate for the preparation of solution for intravenous and intramuscular injection 50 mg.

Lyophilizate for the preparation of solution for intravenous and intramuscular injection 50 mg.